Literature DB >> 28643016

Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.

Masood Alqahtani1,2, Caitlin Edwards3, Natasha Buzzacott3, Karen Carpenter3, Khalid Alsaleh4, Abdulmalik Alsheikh4, Waleed Abozeed4,5, Miral Mashhour2, Afnan Almousa2, Yousef Housawi2, Shareefa Al Hawwaj2, Barry Iacopetta6.   

Abstract

Individuals with Lynch syndrome (LS) have germline variants in DNA mismatch repair (MMR) genes that confer a greatly increased risk of colorectal cancer (CRC), often at a young age. Identification of these individuals has been shown to increase their survival through improved surveillance. We previously identified 33 high risk cases for LS in the Saudi population by screening for microsatellite instability (MSI) in the tumor DNA of 284 young CRC patients. The aim of the present study was to identify MMR gene variants in this cohort of patients. Peripheral blood DNA was obtained from 13 individuals who were at high risk of LS due to positive MSI status and young age (<60 years at diagnosis). Next generation sequencing, Sanger sequencing and Multiplex Ligation-dependent Probe Amplification were used to screen for germline variants in the MLH1, MSH2, MSH6 and PMS2 MMR genes. These were cross-referenced against several variant databases, including the International Society for Gastrointestinal Hereditary Tumors Incorporated database. Variants with pathogenic or likely pathogenic significance were identified in 8 of the 13 high risk cases (62%), comprising 4 in MLH1 and 4 in MSH2. All carriers had a positive family history for CRC or endometrial cancer. Next generation sequencing is an effective strategy for identifying young CRC patients who are at high risk of LS because of positive MSI status. We estimate that 7% of CRC patients aged <60 years in Saudi Arabia are due to LS, potentially involving around 50 new cases per year.

Entities:  

Keywords:  Colorectal cancer; Lynch syndrome; Microsatellite instability; Saudi; Screening

Mesh:

Substances:

Year:  2018        PMID: 28643016     DOI: 10.1007/s10689-017-0015-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  24 in total

1.  The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.

Authors:  W S Samowitz; K Curtin; H H Lin; M A Robertson; D Schaffer; M Nichols; K Gruenthal; M F Leppert; M L Slattery
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

Review 2.  Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome.

Authors:  Linnea M Baudhuin; Lawrence J Burgart; Olga Leontovich; Stephen N Thibodeau
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

4.  Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

Authors:  Tuan A Dinh; Benjamin I Rosner; James C Atwood; C Richard Boland; Sapna Syngal; Hans F A Vasen; Stephen B Gruber; Randall W Burt
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-18

5.  The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer.

Authors:  Harminder Singh; Zoann Nugent; Alain A Demers; Erich V Kliewer; Salaheddin M Mahmud; Charles N Bernstein
Journal:  Gastroenterology       Date:  2010-06-20       Impact factor: 22.682

Review 6.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

7.  Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test.

Authors:  Lyn Schofield; Natasha Watson; Fabienne Grieu; Wei Qi Li; Nik Zeps; Jennet Harvey; Colin Stewart; Michael Abdo; Jack Goldblatt; Barry Iacopetta
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

8.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

9.  Screening for Lynch Syndrome in Young Colorectal Cancer Patients from Saudi Arabia Using Microsatellite Instability as the Initial Test.

Authors:  Masood Alqahtani; Fabienne Grieu; Amerigo Carrello; Benhur Amanuel; Miral Mashour; Rabab Alattas; Khalid Alsaleh; Abdulmalik Alsheikh; Sarah Alqahtani; Barry Iacopetta
Journal:  Asian Pac J Cancer Prev       Date:  2016

Review 10.  Molecular tumor testing for Lynch syndrome in patients with colorectal cancer.

Authors:  Jeremy Matloff; Aimee Lucas; Alexandros D Polydorides; Steven H Itzkowitz
Journal:  J Natl Compr Canc Netw       Date:  2013-11       Impact factor: 11.908

View more
  1 in total

1.  Epidemiology of cancer in Saudi Arabia thru 2010-2019: a systematic review with constrained meta-analysis.

Authors:  Wedad Saeed Alqahtani; Nawaf Abdulrahman Almufareh; Dalia Mostafa Domiaty; Gadah Albasher; Manal Abduallah Alduwish; Huda Alkhalaf; Bader Almuzzaini; Salma Sanhaat Al-Marshidy; Rgya Alfraihi; Abdelbaset Mohamed Elasbali; Hussain Gadelkarim Ahmed; Bassam Ahmed Almutlaq
Journal:  AIMS Public Health       Date:  2020-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.